TPP1 and metabolic disease: In this program, patients from Argentina, Brazil, Chile, and Mexico with epilepsy without a specific cause and who had at least 1 symptom associated with CLN2 were screened for variants in 160 genes associated with epilepsy or metabolic disorders presenting with epilepsy.